论文部分内容阅读
开发中的 hirudin 和 hirulog 可以替代肝素用于包括冠状血管成形术、血栓溶解、反复发作的心绞痛和深部静脉血栓形成等一些疾病的治疗。据称这两种药品作为抗血栓形成制剂具有某些超越肝素的潜在优势:抑制
The development of hirudin and hirulog can replace heparin for the treatment of some diseases including coronary angioplasty, thrombolysis, recurrent angina pectoris and deep venous thrombosis. The two drugs are said to have some potential advantages over heparin as antithrombotic agents: inhibition